185 related articles for article (PubMed ID: 18155604)
1. Evaluation of the radiopacity and cytotoxicity of Portland cements containing bismuth oxide.
Kim EC; Lee BC; Chang HS; Lee W; Hong CU; Min KS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e54-7. PubMed ID: 18155604
[TBL] [Abstract][Full Text] [Related]
2. Radiopacity and cytotoxicity of Portland cement containing zirconia doped bismuth oxide radiopacifiers.
Chen C; Hsieh SC; Teng NC; Kao CK; Lee SY; Lin CK; Yang JC
J Endod; 2014 Feb; 40(2):251-4. PubMed ID: 24461413
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the strength and radiopacity of Portland cement with varying additions of bismuth oxide.
Saliba E; Abbassi-Ghadi S; Vowles R; Camilleri J; Hooper S; Camilleri J
Int Endod J; 2009 Apr; 42(4):322-8. PubMed ID: 19220518
[TBL] [Abstract][Full Text] [Related]
4. Radiopacity and histological assessment of Portland cement plus bismuth oxide.
Coutinho-Filho T; De-Deus G; Klein L; Manera G; Peixoto C; Gurgel-Filho ED
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):e69-77. PubMed ID: 18926734
[TBL] [Abstract][Full Text] [Related]
5. Study of the bismuth oxide concentration required to provide Portland cement with adequate radiopacity for endodontic use.
Bueno CE; Zeferino EG; Manhães LR; Rocha DG; Cunha RS; De Martin AS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):e65-9. PubMed ID: 19101486
[TBL] [Abstract][Full Text] [Related]
6. Chemical composition, radiopacity, and biocompatibility of Portland cement with bismuth oxide.
Hwang YC; Lee SH; Hwang IN; Kang IC; Kim MS; Kim SH; Son HH; Oh WM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Mar; 107(3):e96-102. PubMed ID: 19157923
[TBL] [Abstract][Full Text] [Related]
7. The chemical constitution and biocompatibility of accelerated Portland cement for endodontic use.
Camilleri J; Montesin FE; Di Silvio L; Pitt Ford TR
Int Endod J; 2005 Nov; 38(11):834-42. PubMed ID: 16218977
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the radiopacity of some commercial and experimental root-end filling materials.
Vivan RR; Ordinola-Zapata R; Bramante CM; Bernardineli N; Garcia RB; Hungaro Duarte MA; de Moraes IG
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):e35-8. PubMed ID: 19913718
[TBL] [Abstract][Full Text] [Related]
9. Radiopacity and cytotoxicity of Portland cement associated with niobium oxide micro and nanoparticles.
Mestieri LB; Tanomaru-Filho M; Gomes-Cornélio AL; Salles LP; Bernardi MI; Guerreiro-Tanomaru JM
J Appl Oral Sci; 2014; 22(6):554-9. PubMed ID: 25591023
[TBL] [Abstract][Full Text] [Related]
10. Radiopacity of portland cement associated with different radiopacifying agents.
Húngaro Duarte MA; de Oliveira El Kadre GD; Vivan RR; Guerreiro Tanomaru JM; Tanomaru Filho M; de Moraes IG
J Endod; 2009 May; 35(5):737-40. PubMed ID: 19410095
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo assessment of genotoxicity and cytotoxicity in murine fibroblasts exposed to white MTA or white Portland cement with 15% bismuth oxide.
Zeferino EG; Bueno CE; Oyama LM; Ribeiro DA
Int Endod J; 2010 Oct; 43(10):843-8. PubMed ID: 20722754
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity and osteogenic potential of silicate calcium cements as potential protective materials for pulpal revascularization.
Bortoluzzi EA; Niu LN; Palani CD; El-Awady AR; Hammond BD; Pei DD; Tian FC; Cutler CW; Pashley DH; Tay FR
Dent Mater; 2015 Dec; 31(12):1510-22. PubMed ID: 26494267
[TBL] [Abstract][Full Text] [Related]
13. Marginal adaptation and cytotoxicity of bone cement compared with amalgam and mineral trioxide aggregate as root-end filling materials.
Badr AE
J Endod; 2010 Jun; 36(6):1056-60. PubMed ID: 20478465
[TBL] [Abstract][Full Text] [Related]
14. Comparative physicochemical and biocompatible properties of radiopaque dicalcium silicate cement and mineral trioxide aggregate.
Chiang TY; Ding SJ
J Endod; 2010 Oct; 36(10):1683-7. PubMed ID: 20850678
[TBL] [Abstract][Full Text] [Related]
15. Analysis of radiopacity, pH and cytotoxicity of a new bioceramic material.
Souza LC; Yadlapati M; Dorn SO; Silva R; Letra A
J Appl Oral Sci; 2015; 23(4):383-9. PubMed ID: 26398510
[TBL] [Abstract][Full Text] [Related]
16. In vitro cytotoxicity of white MTA, MTA Fillapex® and Portland cement on human periodontal ligament fibroblasts.
Yoshino P; Nishiyama CK; Modena KC; Santos CF; Sipert CR
Braz Dent J; 2013; 24(2):111-6. PubMed ID: 23780362
[TBL] [Abstract][Full Text] [Related]
17. Radiographic effect of different radiopacifiers on a potential retrograde filling material.
Bortoluzzi EA; Guerreiro-Tanomaru JM; Tanomaru-Filho M; Duarte MA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Oct; 108(4):628-32. PubMed ID: 19699115
[TBL] [Abstract][Full Text] [Related]
18. Replacement of radiopacifier in mineral trioxide aggregate; characterization and determination of physical properties.
Cutajar A; Mallia B; Abela S; Camilleri J
Dent Mater; 2011 Sep; 27(9):879-91. PubMed ID: 21571361
[TBL] [Abstract][Full Text] [Related]
19. Hydration characteristics of calcium silicate cements with alternative radiopacifiers used as root-end filling materials.
Camilleri J
J Endod; 2010 Mar; 36(3):502-8. PubMed ID: 20171371
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic effects of new MTA-based cement formulations on fibroblast-like MDPL-20 cells.
Garcia Lda F; Santos AD; Moraes JC; Costa CA
Braz Oral Res; 2016; 30():. PubMed ID: 26981755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
